Harms in Systematic Reviews Paper 1: An introduction to research on harms

被引:37
作者
Qureshi, Riaz [1 ]
Mayo-Wilson, Evan [2 ]
Li, Tianjing [3 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[2] Indiana Univ Sch Publ Hlth, Dept Epidemiol & Biostat, Bloomington, ID USA
[3] Univ Colorado Anschutz Med Campus, Dept Ophthalmol, Aurora, CO USA
关键词
Harms; Systematic Reviews; Meta-analysis; Synthesis; Clinical Trials; RANDOMIZED CONTROLLED-TRIALS; REAL-WORLD; CLINICAL-TRIALS; ADVERSE EVENTS; SAFETY; METAANALYSIS; OUTCOMES; INTERVENTION; CHALLENGES; POOR;
D O I
10.1016/j.jclinepi.2021.10.023
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: Most systematic reviews of interventions focus on potential benefits. Common methods and assumptions that are appropriate for assessing benefits can be inappropriate for harms. This paper provides a primer on researching harms, particularly in systematic reviews.Study Design and Setting: Commentary describing challenges with assessing harm.Results: Investigators should be familiar with various terminologies used to describe, classify, and group harms. Published reports of clinical trials include limited information about harms, so systematic reviewers should not depend on these studies and journal articles to reach conclusions about harms. Visualizations might improve communication of multiple dimensions of harms such as severity, relatedness, and timing.Conclusion: The terminology, classification, detection, collection, and reporting of harms create unique challenges that take time, expertise, and resources to navigate in both primary studies and evidence syntheses. Systematic reviewers might reach incorrect conclusions if they focus on evidence about harms found in published reports of randomized trials of a particular health problem. Systematic reviews could be improved through better identification and reporting of harms in primary studies and through better training and uptake of appropriate methods for synthesizing evidence about harms.(c) 2021 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license ( http:// creativecommons.org/ licenses/ by/ 4.0/ )
引用
收藏
页码:186 / 196
页数:11
相关论文
共 87 条
[61]   Adverse Event extraction from Structured Product Labels using the Event-based Text-mining of Health Electronic Records (ETHER) system [J].
Pandey, Abhishek ;
Kreimeyer, Kory ;
Foster, Matthew ;
Oanh Dang ;
Ly, Thomas ;
Wang, Wei ;
Forshee, Richard ;
Botsis, Taxiarchis .
HEALTH INFORMATICS JOURNAL, 2019, 25 (04) :1232-1243
[62]   Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies [J].
Papanikolaou, PN ;
Christidi, GD ;
Ioannidis, JPA .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 174 (05) :635-641
[63]  
Peryer G, 2019, Cochrane Handbook for Systematic Reviews of Interventions version 6.0.
[64]   The FDA Sentinel Initiative - An Evolving National Resource [J].
Platt, Richard ;
Brown, Jeffrey S. ;
Robb, Melissa ;
McClellan, Mark ;
Ball, Robert ;
Nguyen, Michael D. ;
Sherman, Rachel E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22) :2091-2093
[65]  
Qureshi R, 2021, J CLIN EPIDEMIOL
[66]   Selective reporting bias of harm outcomes within studies: findings from a cohort of systematic reviews [J].
Saini, Pooja ;
Loke, Yoon K. ;
Gamble, Carrol ;
Altman, Douglas G. ;
Williamson, Paula R. ;
Kirkham, Jamie J. .
BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
[67]   Assessment of Adverse Events in Protocols, Clinical Study Reports, and Published Papers of Trials of Orlistat: A Document Analysis [J].
Schroll, Jeppe Bennekou ;
Penninga, Elisabeth I. ;
Gotzsche, Peter C. .
PLOS MEDICINE, 2016, 13 (08)
[68]   Methods to Compare Adverse Events in Twitter to FAERS, Drug Information Databases, and Systematic Reviews: Proof of Concept with Adalimumab [J].
Smith, Karen ;
Golder, Su ;
Sarker, Abeed ;
Loke, Yoon ;
O'Connor, Karen ;
Gonzalez-Hernandez, Graciela .
DRUG SAFETY, 2018, 41 (12) :1397-1410
[69]   Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists [J].
Smyth, R. M. D. ;
Kirkham, J. J. ;
Jacoby, A. ;
Altman, D. G. ;
Gamble, C. ;
Williamson, P. R. .
BMJ-BRITISH MEDICAL JOURNAL, 2011, 342 :155
[70]  
Tarn Derjung M, 2015, Drugs Ther Perspect, V31, P68